Recent BDRX News
- Receipt of Nasdaq Delisting Determination - Plans to Appeal • GlobeNewswire Inc. • 08/30/2024 08:30:00 PM
- Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement • GlobeNewswire Inc. • 07/19/2024 12:30:00 PM
- Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada • GlobeNewswire Inc. • 07/16/2024 12:30:00 PM
- Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 • GlobeNewswire Inc. • 07/02/2024 12:30:00 PM
- Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapa™ at 12 months in Familial Adenomatous Polyposis (FAP) • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Results of Annual General Meeting • GlobeNewswire Inc. • 06/13/2024 01:35:53 PM
- Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises • GlobeNewswire Inc. • 05/22/2024 12:30:00 PM
- Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- Posting of Annual Report & Notice of AGM - Total Voting Rights • GlobeNewswire Inc. • 05/15/2024 07:57:55 AM
- Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting • GlobeNewswire Inc. • 04/30/2024 03:51:56 PM
- Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) • GlobeNewswire Inc. • 04/26/2024 12:30:00 PM
- Preliminary Results for the Year Ended 31 December 2023 • GlobeNewswire Inc. • 04/19/2024 12:00:00 PM
- Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update • GlobeNewswire Inc. • 02/23/2024 01:30:00 PM
- Biotech Shares Bid Up Premarket Following 9.9% Institutional Stake Disclosure • AllPennyStocks.com • 02/13/2024 01:15:00 PM
- Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- Biodexa Announces Allowance of U.S. Patent Covering Tolimidone • GlobeNewswire Inc. • 02/07/2024 01:30:00 PM
- Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
- Biodexa Appoints Ann Merchant to the Board of Directors • GlobeNewswire Inc. • 12/29/2023 09:05:00 AM
- Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option • GlobeNewswire Inc. • 12/21/2023 09:00:00 PM
- Biodexa Announces Pricing of $5.2 Million Underwritten Public Offering • GlobeNewswire Inc. • 12/19/2023 01:42:13 PM
- Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to Tolimidone, a Phase II Ready Asset for Type 1 Diabetes • GlobeNewswire Inc. • 11/27/2023 02:00:00 PM
- Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
- Interim results for the six months ended 30 June 2023 • GlobeNewswire Inc. • 09/29/2023 08:30:00 PM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM